Warren Buffett: Here’s How to Strike it Rich in 2021

Investors looking to mimic Warren Buffett should stay liquid while stashing stocks like VieMed Healthcare Inc. (TSX:VMD)(NASDAQ:VMD) today.

| More on:
grow dividends

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Investors looked to Warren Buffett for guidance when the COVID-19 pandemic first rattled markets in early 2020. Buffett’s long-term success have made him a legend in this field. Today, I want to discuss how investors can look to follow in the footsteps of the Oracle of Omaha to generate their own investing success in this new year. Let’s dive in.

Warren Buffett: Buy healthcare stocks to start 2021

In the final weeks of 2020, I’d discussed stocks Warren Buffett was buying and selling to close out the year. Historically, Buffett has not been enthusiastic about the pharmaceutical sector. However, the most recent quarter saw Berkshire Hathaway add significant stake in stocks like Merck and Pfizer. Buffett and other big investors are likely looking to cash in on the vaccine surge.

Canadian investors will need to look for other options on the TSX. VieMed Healthcare (TSX:VMD)(NASDAQ:VMD) thrived in 2020, largely on the back of momentum generated due to the pandemic. VieMed provides in-home durable medical equipment to its consumer base. It offers its expertise during the pandemic, supplying ventilators to public and private entities in the healthcare space.

In Q3 2020, the company stated that the pandemic would continue to have a positive impact on its revenue growth going forward. Shares of VieMed have dropped 12% month over month as of close on January 4. The stock possesses a favourable price-to-earnings ratio of 11. Now may be a good time to buy low on this enticing healthcare stock.

Trillium Therapeutics is another equity in the healthcare space that is worth your attention. It is a clinical-stage immuno-oncology company. Shares have soared over 990% year over year as of close on January 4. Biotherapeutics is one of the fastest-growing subsectors in the explosive healthcare space. This company offers nice potential and has posted significant revenue growth in successive quarters.

Should you jump back into gold?

Warren Buffett’s company Berkshire Hathaway dumped over 40% of its stake in Barrick Gold in the third quarter of 2020. The Oracle’s move into gold was surprising to begin with, as he has historically advocated against stashing gold in comparison to standard blue-chip stocks. Gold’s big run in the first half of 2020 was impossible to ignore, even for Warren Buffett.

The yellow metal retreated into the summer and fall and has been outshone by the performance of another alternative asset — Bitcoin. However, the spot price of gold has climbed back above $1,900/ounce to start 2021. Canadian investors may want to play contrarian to Buffett and consider adding gold miners like Kinross in January. Gold should continue to benefit from a weakening U.S. dollar.

One other way to emulate Warren Buffett today

Last month, I’d discussed some warning signs for the broader market. Warren Buffett’s favourite indicator, which measures the combined market capitalizations of publicly traded stocks and divides it by a nation’s gross domestic product (GDP), has hovered around all-time highs in recent weeks. The best way for investors to emulate Buffett in this environment is to pursue liquidity. Take profits in high-performing stocks and consider taking a more conservative angle in the weeks and months ahead.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ambrose O'Callaghan has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Berkshire Hathaway (B shares) and Viemed Healthcare Inc and recommends the following options: short January 2021 $200 puts on Berkshire Hathaway (B shares) and long January 2021 $200 calls on Berkshire Hathaway (B shares).

More on Investing

Investing

KM Throwaway Post

Read more »

Investing

Carlos Test Yoast Metadata

Read more »

Investing

KM Ad Test

This is my excerpt.

Read more »

Investing

Test post for affiliate partner mockups

Updated: 9/17/2024. This post was not sponsored. The views and opinions expressed in this review are purely those of the…

Read more »

Investing

Testing Ecap Error

Premium content from Motley Fool Stock Advisor We here at Motley Fool Stock Advisor believe investors should own at least…

Read more »

Investing

TSX Today: Testing the Ad for James

la la la dee dah.

Read more »

Lady holding remote control pointed towards a TV
Investing

2 Streaming Stocks to Buy Now and 1 to Run From

There are streaming stocks on the TSX that are worth paying attention to in 2023 and beyond.

Read more »

A red umbrella stands higher than a crowd of black umbrellas.
Stocks for Beginners

Top Recession-Resilient TSX Stocks to Buy With $3,000

It's time to increase your exposure to defensives!

Read more »